ONPH Stock Overview – The Average Joe
Business Economy Tech Subscribe About Us
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.

PNK:ONPH

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

Description

Loading...

Price Performance

1M 6M 1Y 5Y 10Y
$ONPH N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A

Valuation

P/E Ratio (TTM) P/S Ratio (TTM)
Oncology Pharma Inc. Loading... Loading...
Sector Name Loading... N/A

Related

RGBPRegen BioPharma, Inc.23.5%
PPCBDPropanc Biopharma, Inc.-31.3%
KLDOKaleido Biosciences, Inc.0.0%
RGRXRegeneRx Biopharmaceuticals, Inc.0.0%
RGBPPRegen BioPharma, Inc.-63.2%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2000FY 2001FY 2002FY 2003FY 2004FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue1M4M4M3M1M0M0M0M0M0M
Growth Rate-303.8%-8.5%-10.7%-64.0%-100.0%0.0%0.0%0.0%0.0%
EBITDA-4M-1M-2M-1M-2M-1M0M-14M0M0M
EBITDA Margin-435.6%-27.0%-45.0%-40.1%-148.3%0.0%0.0%0.0%0.0%0.0%
Net Income-5M-2M-2M-2M-2M-1M0M-97M-105M0M
NI Margin-454.8%-39.7%-53.1%-46.3%-132.5%0.0%0.0%0.0%0.0%0.0%